Methods for treatment of cancer with an anti-tigit antagonist antibody
US-2024424092-A1 · Dec 26, 2024 · US
US9364492B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9364492-B2 |
| Application number | US-52306508-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 18, 2008 |
| Priority date | Jan 19, 2007 |
| Publication date | Jun 14, 2016 |
| Grant date | Jun 14, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a method for preparing a glycoside of a flavonoid compound, which comprises the step of treating flavonoid and a glycosyl donor with an enzymatic agent having glycosylation activity and being derived from the genus Trichoderma (preferably Trichoderma viride or Trichoderma reesei ). Such a flavonoid compound includes a catechin compound or a methylated derivative thereof, and the glycosyl donor includes a carbohydrate containing a maltotriose residue (preferably maltotriose, maltotetraose, maltopentaose, maltohexaose, maltoheptaose, dextrin, γ-cyclodextrin or soluble starch). Glycosides obtained by the present invention have higher water solubility, improved taste, and increased stability. The present invention also provides novel glycosides of catechin compounds, which are obtained by the method of the present invention.
Opening claim text (preview).
The invention claimed is: 1. A compound represented by the following formula: wherein at least one of R 1 to R 4 represents an α-linked glucose residue or maltose residue or maltooligosaccharide residue, and each of the others represents OH; R 5 represents OH or H; and X represents H or a galloyl group, provided that the following compounds are excluded: a compound in which R 1 represents glucose, R 2 -R 4 represent OH, and R 5 and X represent H; a compound in which R 2 represents glucose, R 1 and R 3 -R 4 represent OH, and R 5 and X represent H; a compound in which R 4 represents glucose, R 1 -R 3 represent OH, and R 5 and represent H; a compound in which R 2 represents maltose, R 1 and R 3 -R 4 represent OH, and R 5 and X represent H; a compound in which R 3 represents glucose, R 1 -R 2 and R 4 represent OH, and R 5 and X represent H; a compound in which R 1 represents maltose, R 2 -R 4 represent OH, and R 5 and X represent H; a compound in which R 3 represents glucose, R 1 -R 2 and R 4 represent OH, and R 5 and X represent H; a compound in which R 3 represents glucose, R 1 -R 2 and R 4 -R 5 represent OH, and X represents H; a compound in which R 2 -R 3 represent glucose, R 1 and R 4 -R 5 represent OH, and X represents H; a compound in which R 1 and R 3 represent glucose, R 2 and R 4 -R 5 represent OH, and X represents H; a compound in which R 3 represents glucose, R 1 -R 2 and R 4 -R 5 represent OH, and X represents H; a compound in which R 4 represents glucose, R 1 -R 3 and R 5 represent OH, and X represents H; a compound in which R 3 represents glucose, R 1 -R 2 and R 4 represent OH, R 5 represents H, and X represents a galloyl group; a compound in which R 2 -R 3 represent glucose, R 1 and R 4 -R 5 represent OH, and X represents a galloyl group; a compound in which R 3 represents glucose, R 1 -R 2 and R 4 -R 5 represent OH, and X represents a galloyl group; a compound in which R 4 represents glucose, R 1 -R 3 and R 5 represent OH, and X represents a galloyl group; a compound in which R 4 represents glucose, R 1 -R 3 represent OH, R 5 represents H, and X represents a galloyl group; a compound in which R 2 represents glucose, R 1 and R 3 -R 5 represent OH, and X represents a galloyl group; a compound in which R 2 and R 4 represent glucose, R 1 , R 3 , and R 5 represent OH, and X represents a galloyl group; a compound in which R 2 -R 3 represent glucose, R 1 and R 4 represent OH, and R 5 and X represent H; a compound in which R 1 and R 3 represent glucose, R 2 and R 4 represent OH, and R 5 and X represent H; a compound in which R 3 -R 4 represent glucose, R 1 -R 2 represent OH, and R 5 and X represent H; a compound in which R 1 and R 4 represent glucose, R 2 -R 3 represent OH, and R 5 and X represent H; a compound in which R 2 and R 4 represent glucose, R 1 , R 3 , and R 5 represent OH, and X represents H; and a compound in which R 2 and R 4 represent glucose, R 1 and R 3 represent OH, and R 5 and X represent H. 2. The compound according to claim 1 , which is selected from the group consisting of: 5-O-α-D-glucopyranosyl-(−)-epigallocatechin-3-O-gallate; 7-O-(4-O-α-D-glucopyranosyl-α-D-glucopyranosyl)-(−)-epigallocatechin-3-O-gallate; 4′-O-(4-O-α-D-glucopyranosyl-α-D-glucopyranosyl)-(+)-catechin; 3′-O-(4-O-α-D-glucopyranosyl-α-D-glucopyranosyl)-(+)-catechin; and 3′-O-(4-O-α-D-glucopyranosyl-α-D-glucopyranosyl)-(−)-epigallocatechin-3-O-gallate. 3. A food, pharmaceutical or cosmetic composition, which comprises the compound according to claim 1 . 4. A beverage, which comprises the composition according to claim 3 . 5. A compound represented by the following formula: wherein at least one of R 1 , R 2 , and R 4 represents an α-linked glucose residue or maltose residue or maltooligosaccharide residue, and each of the others represents OH; R 3 represents a maltose residue; R 5 represents OH or H; and X represents H or a galloyl group. 6. A glycoside of a flavonoid compound selected from the following: 5-O-α-D-glucopyranosyl-(−)-epigallocatechin-3-O-gallate; 3′-O-(4-O-α-D-glucopyranosyl-α-D-glucopyranosyl)-(+)-catechin; and 3′-O-(4-O-α-D-glucopyranosyl-α-D-glucopyranosyl)-(−)-epigallocatechin-3-O-gallate. 7. A food, pharmaceutical or cosmetic composition, which comprises the compound according to claim 2 . 8. A beverage, which comprises the composition according to claim 7 .
Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors · CPC title
General protective or antinoxious agents · CPC title
Antihyperlipidemics · CPC title
Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title
Antihypertensives · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.